Zurich Cantonal Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.82M | Buy |
5,245
+1,111
| +27% | +$569K | 0.01% | 950 |
|
|
2026
Q1 | $2.16M | Buy |
4,134
+1,156
| +39% | +$552K | ﹤0.01% | 1005 |
|
|
2025
Q4 | $1.73M | Buy |
2,978
+855
| +40% | +$437K | ﹤0.01% | 1024 |
|
|
2025
Q3 | $974K | Sell |
2,123
-11
| -0.5% | -$4.1K | ﹤0.01% | 1300 |
|
|
2025
Q2 | $646K | Sell |
2,134
-4
| -0.2% | -$1.19K | ﹤0.01% | 1501 |
|
|
2025
Q1 | $708K | Sell |
2,138
-291
| -12% | -$95.6K | ﹤0.01% | 1383 |
|
|
2024
Q4 | $750K | Sell |
2,429
-13
| -0.5% | -$3.66K | ﹤0.01% | 1386 |
|
|
2024
Q3 | $518K | Sell |
2,442
-2
| -0.1% | -$512 | ﹤0.01% | 1540 |
|
|
2024
Q2 | $685K | Buy |
2,444
+387
| +19% | +$92.1K | ﹤0.01% | 1271 |
|
|
2024
Q1 | $549K | Buy |
2,057
+32
| +2% | +$7.54K | ﹤0.01% | 1407 |
|
|
2023
Q4 | $469K | Sell |
2,025
-14
| -0.7% | -$2.45K | ﹤0.01% | 1543 |
|
|
2023
Q3 | $298K | Buy |
2,039
+284
| +16% | +$53.5K | ﹤0.01% | 1708 |
|
|
2023
Q2 | $405K | Buy |
1,755
+122
| +7% | +$33K | ﹤0.01% | 1483 |
|
|
2023
Q1 | $396K | Buy |
1,633
+94
| +6% | +$25.6K | ﹤0.01% | 1431 |
|
|
2022
Q4 | $447K | Sell |
1,539
-54
| -3% | -$5.28K | ﹤0.01% | 1320 |
|
|
2022
Q3 | $104K | Hold |
1,593
| – | – | ﹤0.01% | 2189 |
|
|
2022
Q2 | $114K | Sell |
1,593
-33
| -2% | -$2.43K | ﹤0.01% | 2146 |
|
|
2022
Q1 | $160K | Buy |
1,626
+367
| +29% | +$30.9K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $107K | Hold |
1,259
| – | – | ﹤0.01% | 2478 |
|
|
2021
Q3 | $100K | Hold |
1,259
| – | – | ﹤0.01% | 2333 |
|
|
2021
Q2 | $123K | Hold |
1,259
| – | – | ﹤0.01% | 2104 |
|
|
2021
Q1 | $147K | Hold |
1,259
| – | – | ﹤0.01% | 1958 |
|
|
2020
Q4 | $140K | Hold |
1,259
| – | – | ﹤0.01% | 2056 |
|
|
2020
Q3 | $149K | Hold |
1,259
| – | – | ﹤0.01% | 1795 |
|
|
2020
Q2 | $143K | Buy |
1,259
+757
| +151% | +$74.4K | ﹤0.01% | 1751 |
|
|
2020
Q1 | $34K | Hold |
502
| – | – | ﹤0.01% | 2128 |
|
|
2019
Q4 | $46K | Hold |
502
| – | – | ﹤0.01% | 2184 |
|
|
2019
Q3 | $43K | Hold |
502
| – | – | ﹤0.01% | 2140 |
|
|
2019
Q2 | $53K | Hold |
502
| – | – | ﹤0.01% | 2022 |
|
|
2019
Q1 | $63K | Hold |
502
| – | – | ﹤0.01% | 1865 |
|
|
2018
Q4 | $57K | Hold |
502
| – | – | ﹤0.01% | 1953 |
|
|
2018
Q3 | $107K | Hold |
502
| – | – | ﹤0.01% | 1670 |
|
|
2018
Q2 | $140K | Buy |
+502
| New | +$88.2K | ﹤0.01% | 1467 |
|
Other funds holding MDGL
BBA
RI
JT
ACA
PC
Zurich Cantonal Bank's MDGL Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Madrigal Pharmaceuticals (MDGL) stake by 27% in Q2 2026, buying an estimated $569K and bringing the position to 5,245 shares worth $2.82M. The position accounts for 0.01% of the portfolio, ranked #950.
Zurich Cantonal Bank first reported a position in MDGL in Q2 2018 and has held it in 33 quarters since. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.
- Zurich Cantonal Bank held 5,245 shares of Madrigal Pharmaceuticals worth $2.82M as of Q2 2026.
- Zurich Cantonal Bank bought 1,111 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $569K.
- Madrigal Pharmaceuticals made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #950 holding.
- Zurich Cantonal Bank first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.